APO Research
Talk to an analyst

APO RESEARCH · REPORT

Red Blood Cell Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Red Blood Cell Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025194 pages

Choose your research edition.

Industry ResearchRed Blood Cell Products Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Red Blood Cell Products Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Red Blood Cell Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Red Blood Cell Products Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Red Blood Cell Products Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Red Blood Cell Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Red Blood Cell Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Red Blood Cell Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Red Blood Cell Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Red Blood Cell Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Red Blood Cell Products include China National Biotec Group, Weiguang Biological, Tiantan Biological, Shanghai RAAS Blood Products, Pilin Biological, Hualan Biological, Boyaa Bio-pharmaceutical, Bohui Innovation and Takeda Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Red Blood Cell Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Red Blood Cell Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Red Blood Cell Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Red Blood Cell Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Red Blood Cell Products Segment by Company

China National Biotec Group

Weiguang Biological

Tiantan Biological

Shanghai RAAS Blood Products

Pilin Biological

Hualan Biological

Boyaa Bio-pharmaceutical

Bohui Innovation

Takeda Pharmaceutical

Sangamo Therapeutics

Octapharma

LFB Group

Kedrion

Kamada

Hemophilia Federation Europe

Grifols

Emergent BioSolutions

CSL Behring

Biotest

American Red Cross

Red Blood Cell Products Segment by Type

Washed Red Blood Cells

Concentrated Red Blood Cells

Frozen Red Blood Cells

Red Blood Cell Suspension

Irradiated Red Blood Cells

Others

Red Blood Cell Products Segment by Application

Blood Disease Supportive Treatment

Special Disease Management

Anemia Treatment

Acute Hemorrhage

Red Blood Cell Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Red Blood Cell Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Red Blood Cell Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Red Blood Cell Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Red Blood Cell Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Red Blood Cell Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Red Blood Cell Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Red Blood Cell Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Red Blood Cell Products Industry Trends Table 2. Red Blood Cell Products Industry Drivers Table 3. Red Blood Cell Products Industry Opportunities and Challenges Table 4. Red Blood Cell Products Industry Restraints Table 5. Global Red Blood Cell Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Red Blood Cell Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Red Blood Cell Products Sales by Manufacturers (units) & (2021-2026) Table 8. Global Red Blood Cell Products Sales Market Share by Manufacturers Table 9. Global Red Blood Cell Products Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Red Blood Cell Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Red Blood Cell Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Red Blood Cell Products Manufacturers, Product Type & Application Table 13. Global Red Blood Cell Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Red Blood Cell Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Washed Red Blood Cells Table 17. Major Manufacturers of Concentrated Red Blood Cells Table 18. Major Manufacturers of Frozen Red Blood Cells Table 19. Major Manufacturers of Red Blood Cell Suspension Table 20. Major Manufacturers of Irradiated Red Blood Cells Table 21. Major Manufacturers of Others Table 22. Global Red Blood Cell Products Sales by Type 2021 VS 2025 VS 2032 (units) Table 23. Global Red Blood Cell Products Sales by Type (2021-2026) & (units) Table 24. Global Red Blood Cell Products Sales by Type (2027-2032) & (units) Table 25. Global Red Blood Cell Products Sales Market Share by Type (2021-2026) Table 26. Global Red Blood Cell Products Sales Market Share by Type (2027-2032) Table 27. Global Red Blood Cell Products Revenue by Type 2021 VS 2025 VS 2032 (units) Table 28. Global Red Blood Cell Products Revenue by Type (2021-2026) & (units) Table 29. Global Red Blood Cell Products Revenue by Type (2027-2032) & (units) Table 30. Global Red Blood Cell Products Revenue Market Share by Type (2021-2026) Table 31. Global Red Blood Cell Products Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Blood Disease Supportive Treatment Table 33. Major Manufacturers of Special Disease Management Table 34. Major Manufacturers of Anemia Treatment Table 35. Major Manufacturers of Acute Hemorrhage Table 36. Global Red Blood Cell Products Sales by Application 2021 VS 2025 VS 2032 (units) Table 37. Global Red Blood Cell Products Sales by Application (2021-2026) & (units) Table 38. Global Red Blood Cell Products Sales by Application (2027-2032) & (units) Table 39. Global Red Blood Cell Products Sales Market Share by Application (2021-2026) Table 40. Global Red Blood Cell Products Sales Market Share by Application (2027-2032) Table 41. Global Red Blood Cell Products Revenue by Application 2021 VS 2025 VS 2032 (units) Table 42. Global Red Blood Cell Products Revenue by Application (2021-2026) & (units) Table 43. Global Red Blood Cell Products Revenue by Application (2027-2032) & (units) Table 44. Global Red Blood Cell Products Revenue Market Share by Application (2021-2026) Table 45. Global Red Blood Cell Products Revenue Market Share by Application (2027-2032) Table 46. Global Red Blood Cell Products Sales by Region: 2021 VS 2025 VS 2032 (units) Table 47. Global Red Blood Cell Products Sales by Region (2021-2026) & (units) Table 48. Global Red Blood Cell Products Sales Market Share by Region (2021-2026) Table 49. Global Red Blood Cell Products Sales Forecasted by Region (2027-2032) & (units) Table 50. Global Red Blood Cell Products Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Red Blood Cell Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 52. North America Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 53. North America Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 54. Europe Red Blood Cell Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 55. Europe Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 56. Europe Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 57. Asia Pacific Red Blood Cell Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 58. Asia Pacific Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 59. Asia Pacific Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 60. South America, Middle East and Africa Red Blood Cell Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 61. South America, Middle East and Africa Red Blood Cell Products Sales by Country (2021-2026) & (units) Table 62. South America, Middle East and Africa Red Blood Cell Products Sales by Country (2027-2032) & (units) Table 63. Global Red Blood Cell Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Red Blood Cell Products Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Red Blood Cell Products Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Red Blood Cell Products Revenue Market Share by Region (2021-2026) Table 67. Global Red Blood Cell Products Revenue Market Share by Region (2027-2032) Table 68. China National Biotec Group Company Information Table 69. China National Biotec Group Business Overview Table 70. China National Biotec Group Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. China National Biotec Group Red Blood Cell Products Product Portfolio Table 72. China National Biotec Group Recent Development Table 73. Weiguang Biological Company Information Table 74. Weiguang Biological Business Overview Table 75. Weiguang Biological Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Weiguang Biological Red Blood Cell Products Product Portfolio Table 77. Weiguang Biological Recent Development Table 78. Tiantan Biological Company Information Table 79. Tiantan Biological Business Overview Table 80. Tiantan Biological Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tiantan Biological Red Blood Cell Products Product Portfolio Table 82. Tiantan Biological Recent Development Table 83. Shanghai RAAS Blood Products Company Information Table 84. Shanghai RAAS Blood Products Business Overview Table 85. Shanghai RAAS Blood Products Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio Table 87. Shanghai RAAS Blood Products Recent Development Table 88. Pilin Biological Company Information Table 89. Pilin Biological Business Overview Table 90. Pilin Biological Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pilin Biological Red Blood Cell Products Product Portfolio Table 92. Pilin Biological Recent Development Table 93. Hualan Biological Company Information Table 94. Hualan Biological Business Overview Table 95. Hualan Biological Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hualan Biological Red Blood Cell Products Product Portfolio Table 97. Hualan Biological Recent Development Table 98. Boyaa Bio-pharmaceutical Company Information Table 99. Boyaa Bio-pharmaceutical Business Overview Table 100. Boyaa Bio-pharmaceutical Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio Table 102. Boyaa Bio-pharmaceutical Recent Development Table 103. Bohui Innovation Company Information Table 104. Bohui Innovation Business Overview Table 105. Bohui Innovation Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bohui Innovation Red Blood Cell Products Product Portfolio Table 107. Bohui Innovation Recent Development Table 108. Takeda Pharmaceutical Company Information Table 109. Takeda Pharmaceutical Business Overview Table 110. Takeda Pharmaceutical Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Takeda Pharmaceutical Red Blood Cell Products Product Portfolio Table 112. Takeda Pharmaceutical Recent Development Table 113. Sangamo Therapeutics Company Information Table 114. Sangamo Therapeutics Business Overview Table 115. Sangamo Therapeutics Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sangamo Therapeutics Red Blood Cell Products Product Portfolio Table 117. Sangamo Therapeutics Recent Development Table 118. Octapharma Company Information Table 119. Octapharma Business Overview Table 120. Octapharma Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Octapharma Red Blood Cell Products Product Portfolio Table 122. Octapharma Recent Development Table 123. LFB Group Company Information Table 124. LFB Group Business Overview Table 125. LFB Group Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. LFB Group Red Blood Cell Products Product Portfolio Table 127. LFB Group Recent Development Table 128. Kedrion Company Information Table 129. Kedrion Business Overview Table 130. Kedrion Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Kedrion Red Blood Cell Products Product Portfolio Table 132. Kedrion Recent Development Table 133. Kamada Company Information Table 134. Kamada Business Overview Table 135. Kamada Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Kamada Red Blood Cell Products Product Portfolio Table 137. Kamada Recent Development Table 138. Hemophilia Federation Europe Company Information Table 139. Hemophilia Federation Europe Business Overview Table 140. Hemophilia Federation Europe Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Hemophilia Federation Europe Red Blood Cell Products Product Portfolio Table 142. Hemophilia Federation Europe Recent Development Table 143. Grifols Company Information Table 144. Grifols Business Overview Table 145. Grifols Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Grifols Red Blood Cell Products Product Portfolio Table 147. Grifols Recent Development Table 148. Emergent BioSolutions Company Information Table 149. Emergent BioSolutions Business Overview Table 150. Emergent BioSolutions Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Emergent BioSolutions Red Blood Cell Products Product Portfolio Table 152. Emergent BioSolutions Recent Development Table 153. CSL Behring Company Information Table 154. CSL Behring Business Overview Table 155. CSL Behring Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. CSL Behring Red Blood Cell Products Product Portfolio Table 157. CSL Behring Recent Development Table 158. Biotest Company Information Table 159. Biotest Business Overview Table 160. Biotest Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Biotest Red Blood Cell Products Product Portfolio Table 162. Biotest Recent Development Table 163. American Red Cross Company Information Table 164. American Red Cross Business Overview Table 165. American Red Cross Red Blood Cell Products Sales (units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. American Red Cross Red Blood Cell Products Product Portfolio Table 167. American Red Cross Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Red Blood Cell Products Distributors List Table 171. Red Blood Cell Products Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Red Blood Cell Products Product Image Figure 2. Global Red Blood Cell Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Red Blood Cell Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Red Blood Cell Products Sales (2021-2032) & (units) Figure 5. Global Red Blood Cell Products Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Red Blood Cell Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Washed Red Blood Cells Image Figure 9. Concentrated Red Blood Cells Image Figure 10. Frozen Red Blood Cells Image Figure 11. Red Blood Cell Suspension Image Figure 12. Irradiated Red Blood Cells Image Figure 13. Others Image Figure 14. Global Red Blood Cell Products Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 15. Global Red Blood Cell Products Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Red Blood Cell Products Sales Market Share by Type (2021-2032) Figure 17. Global Red Blood Cell Products Revenue by Type (2021 VS 2025 VS 2032) & (units) Figure 18. Global Red Blood Cell Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Red Blood Cell Products Revenue Market Share by Type (2021-2032) Figure 20. Blood Disease Supportive Treatment Image Figure 21. Special Disease Management Image Figure 22. Anemia Treatment Image Figure 23. Acute Hemorrhage Image Figure 24. Global Red Blood Cell Products Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 25. Global Red Blood Cell Products Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Red Blood Cell Products Sales Market Share by Application (2021-2032) Figure 27. Global Red Blood Cell Products Revenue by Application (2021 VS 2025 VS 2032) & (units) Figure 28. Global Red Blood Cell Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Red Blood Cell Products Revenue Market Share by Application (2021-2032) Figure 30. North America Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 31. North America Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 32. U.S. Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 33. Canada Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 34. Mexico Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 35. Europe Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 36. Europe Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 37. Germany Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 38. France Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 39. U.K. Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 40. Italy Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 41. Netherlands Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 42. Asia Pacific Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 43. Asia Pacific Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 44. China Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 45. Japan Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 46. South Korea Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 47. Southeast Asia Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 48. India Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 49. Australia Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 50. South America, Middle East and Africa Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 51. South America, Middle East and Africa Red Blood Cell Products Sales Market Share by Country (2021-2032) Figure 52. Brazil Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 53. South Africa Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 54. Saudi Arabia Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 55. Turkey Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 56. Argentina Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 57. UAE Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 58. Egypt Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 59. Chile Red Blood Cell Products Sales and Growth Rate (2021-2032) & (units) Figure 60. Global Red Blood Cell Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Red Blood Cell Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Figure 63. North America Red Blood Cell Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Figure 65. Europe Red Blood Cell Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Red Blood Cell Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Red Blood Cell Products Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Red Blood Cell Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Red Blood Cell Products Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Red Blood Cell Products Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Washed Red Blood Cells
  • Concentrated Red Blood Cells
  • Frozen Red Blood Cells
  • Red Blood Cell Suspension
  • Irradiated Red Blood Cells
  • Others
Applications
  • Blood Disease Supportive Treatment
  • Special Disease Management
  • Anemia Treatment
  • Acute Hemorrhage
Companies covered
  • China National Biotec Group
  • Weiguang Biological
  • Tiantan Biological
  • Shanghai RAAS Blood Products
  • Pilin Biological
  • Hualan Biological
  • Boyaa Bio-pharmaceutical
  • Bohui Innovation
  • Takeda Pharmaceutical
  • Sangamo Therapeutics
  • Octapharma
  • LFB Group
  • Kedrion
  • Kamada
  • Hemophilia Federation Europe
  • Grifols
  • Emergent BioSolutions
  • CSL Behring
  • Biotest
  • American Red Cross

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Red Blood Cell Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Red Blood Cell Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Red Blood Cell Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Red Blood Cell Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Red Blood Cell Products Market Dynamics
  1. 2.1 Red Blood Cell Products Industry Trends
  2. 2.2 Red Blood Cell Products Industry Drivers
  3. 2.3 Red Blood Cell Products Industry Opportunities and Challenges
  4. 2.4 Red Blood Cell Products Industry Restraints
3 Red Blood Cell Products Market by Manufacturers
  1. 3.1 Global Red Blood Cell Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Red Blood Cell Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global Red Blood Cell Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Red Blood Cell Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Red Blood Cell Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Red Blood Cell Products Manufacturers, Product Type & Application
  7. 3.7 Global Red Blood Cell Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Red Blood Cell Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Red Blood Cell Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Red Blood Cell Products Tier 1, Tier 2, and Tier 3
4 Red Blood Cell Products Market by Type
  1. 4.1 Red Blood Cell Products Type Introduction
  2. 4.1.1 Washed Red Blood Cells
  3. 4.1.2 Concentrated Red Blood Cells
  4. 4.1.3 Frozen Red Blood Cells
  5. 4.1.4 Red Blood Cell Suspension
  6. 4.1.5 Irradiated Red Blood Cells
  7. 4.1.6 Others
  8. 4.2 Global Red Blood Cell Products Sales by Type
  9. 4.2.1 Global Red Blood Cell Products Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Red Blood Cell Products Sales by Type (2021-2032)
  11. 4.2.3 Global Red Blood Cell Products Sales Market Share by Type (2021-2032)
  12. 4.3 Global Red Blood Cell Products Revenue by Type
  13. 4.3.1 Global Red Blood Cell Products Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Red Blood Cell Products Revenue by Type (2021-2032)
  15. 4.3.3 Global Red Blood Cell Products Revenue Market Share by Type (2021-2032)
5 Red Blood Cell Products Market by Application
  1. 5.1 Red Blood Cell Products Application Introduction
  2. 5.1.1 Blood Disease Supportive Treatment
  3. 5.1.2 Special Disease Management
  4. 5.1.3 Anemia Treatment
  5. 5.1.4 Acute Hemorrhage
  6. 5.2 Global Red Blood Cell Products Sales by Application
  7. 5.2.1 Global Red Blood Cell Products Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Red Blood Cell Products Sales by Application (2021-2032)
  9. 5.2.3 Global Red Blood Cell Products Sales Market Share by Application (2021-2032)
  10. 5.3 Global Red Blood Cell Products Revenue by Application
  11. 5.3.1 Global Red Blood Cell Products Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Red Blood Cell Products Revenue by Application (2021-2032)
  13. 5.3.3 Global Red Blood Cell Products Revenue Market Share by Application (2021-2032)
6 Global Red Blood Cell Products Sales by Region
  1. 6.1 Global Red Blood Cell Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Red Blood Cell Products Sales by Region (2021-2032)
  3. 6.2.1 Global Red Blood Cell Products Sales by Region (2021-2026)
  4. 6.2.2 Global Red Blood Cell Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Red Blood Cell Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Red Blood Cell Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Red Blood Cell Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Red Blood Cell Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Red Blood Cell Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Red Blood Cell Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Red Blood Cell Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Red Blood Cell Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Red Blood Cell Products Revenue by Region
  1. 7.1 Global Red Blood Cell Products Revenue by Region
  2. 7.1.1 Global Red Blood Cell Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Red Blood Cell Products Revenue by Region (2021-2026)
  4. 7.1.3 Global Red Blood Cell Products Revenue by Region (2027-2032)
  5. 7.1.4 Global Red Blood Cell Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Red Blood Cell Products Revenue (2021-2032)
  8. 7.2.2 North America Red Blood Cell Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Red Blood Cell Products Revenue (2021-2032)
  11. 7.3.2 Europe Red Blood Cell Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Red Blood Cell Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Red Blood Cell Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Red Blood Cell Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Red Blood Cell Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 China National Biotec Group
  2. 8.1.1 China National Biotec Group Company Information
  3. 8.1.2 China National Biotec Group Business Overview
  4. 8.1.3 China National Biotec Group Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 China National Biotec Group Red Blood Cell Products Product Portfolio
  6. 8.1.5 China National Biotec Group Recent Developments
  7. 8.2 Weiguang Biological
  8. 8.2.1 Weiguang Biological Company Information
  9. 8.2.2 Weiguang Biological Business Overview
  10. 8.2.3 Weiguang Biological Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Weiguang Biological Red Blood Cell Products Product Portfolio
  12. 8.2.5 Weiguang Biological Recent Developments
  13. 8.3 Tiantan Biological
  14. 8.3.1 Tiantan Biological Company Information
  15. 8.3.2 Tiantan Biological Business Overview
  16. 8.3.3 Tiantan Biological Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tiantan Biological Red Blood Cell Products Product Portfolio
  18. 8.3.5 Tiantan Biological Recent Developments
  19. 8.4 Shanghai RAAS Blood Products
  20. 8.4.1 Shanghai RAAS Blood Products Company Information
  21. 8.4.2 Shanghai RAAS Blood Products Business Overview
  22. 8.4.3 Shanghai RAAS Blood Products Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai RAAS Blood Products Red Blood Cell Products Product Portfolio
  24. 8.4.5 Shanghai RAAS Blood Products Recent Developments
  25. 8.5 Pilin Biological
  26. 8.5.1 Pilin Biological Company Information
  27. 8.5.2 Pilin Biological Business Overview
  28. 8.5.3 Pilin Biological Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pilin Biological Red Blood Cell Products Product Portfolio
  30. 8.5.5 Pilin Biological Recent Developments
  31. 8.6 Hualan Biological
  32. 8.6.1 Hualan Biological Company Information
  33. 8.6.2 Hualan Biological Business Overview
  34. 8.6.3 Hualan Biological Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hualan Biological Red Blood Cell Products Product Portfolio
  36. 8.6.5 Hualan Biological Recent Developments
  37. 8.7 Boyaa Bio-pharmaceutical
  38. 8.7.1 Boyaa Bio-pharmaceutical Company Information
  39. 8.7.2 Boyaa Bio-pharmaceutical Business Overview
  40. 8.7.3 Boyaa Bio-pharmaceutical Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Boyaa Bio-pharmaceutical Red Blood Cell Products Product Portfolio
  42. 8.7.5 Boyaa Bio-pharmaceutical Recent Developments
  43. 8.8 Bohui Innovation
  44. 8.8.1 Bohui Innovation Company Information
  45. 8.8.2 Bohui Innovation Business Overview
  46. 8.8.3 Bohui Innovation Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bohui Innovation Red Blood Cell Products Product Portfolio
  48. 8.8.5 Bohui Innovation Recent Developments
  49. 8.9 Takeda Pharmaceutical
  50. 8.9.1 Takeda Pharmaceutical Company Information
  51. 8.9.2 Takeda Pharmaceutical Business Overview
  52. 8.9.3 Takeda Pharmaceutical Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Pharmaceutical Red Blood Cell Products Product Portfolio
  54. 8.9.5 Takeda Pharmaceutical Recent Developments
  55. 8.10 Sangamo Therapeutics
  56. 8.10.1 Sangamo Therapeutics Company Information
  57. 8.10.2 Sangamo Therapeutics Business Overview
  58. 8.10.3 Sangamo Therapeutics Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sangamo Therapeutics Red Blood Cell Products Product Portfolio
  60. 8.10.5 Sangamo Therapeutics Recent Developments
  61. 8.11 Octapharma
  62. 8.11.1 Octapharma Company Information
  63. 8.11.2 Octapharma Business Overview
  64. 8.11.3 Octapharma Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Octapharma Red Blood Cell Products Product Portfolio
  66. 8.11.5 Octapharma Recent Developments
  67. 8.12 LFB Group
  68. 8.12.1 LFB Group Company Information
  69. 8.12.2 LFB Group Business Overview
  70. 8.12.3 LFB Group Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 LFB Group Red Blood Cell Products Product Portfolio
  72. 8.12.5 LFB Group Recent Developments
  73. 8.13 Kedrion
  74. 8.13.1 Kedrion Company Information
  75. 8.13.2 Kedrion Business Overview
  76. 8.13.3 Kedrion Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Kedrion Red Blood Cell Products Product Portfolio
  78. 8.13.5 Kedrion Recent Developments
  79. 8.14 Kamada
  80. 8.14.1 Kamada Company Information
  81. 8.14.2 Kamada Business Overview
  82. 8.14.3 Kamada Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kamada Red Blood Cell Products Product Portfolio
  84. 8.14.5 Kamada Recent Developments
  85. 8.15 Hemophilia Federation Europe
  86. 8.15.1 Hemophilia Federation Europe Company Information
  87. 8.15.2 Hemophilia Federation Europe Business Overview
  88. 8.15.3 Hemophilia Federation Europe Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hemophilia Federation Europe Red Blood Cell Products Product Portfolio
  90. 8.15.5 Hemophilia Federation Europe Recent Developments
  91. 8.16 Grifols
  92. 8.16.1 Grifols Company Information
  93. 8.16.2 Grifols Business Overview
  94. 8.16.3 Grifols Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Grifols Red Blood Cell Products Product Portfolio
  96. 8.16.5 Grifols Recent Developments
  97. 8.17 Emergent BioSolutions
  98. 8.17.1 Emergent BioSolutions Company Information
  99. 8.17.2 Emergent BioSolutions Business Overview
  100. 8.17.3 Emergent BioSolutions Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Emergent BioSolutions Red Blood Cell Products Product Portfolio
  102. 8.17.5 Emergent BioSolutions Recent Developments
  103. 8.18 CSL Behring
  104. 8.18.1 CSL Behring Company Information
  105. 8.18.2 CSL Behring Business Overview
  106. 8.18.3 CSL Behring Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CSL Behring Red Blood Cell Products Product Portfolio
  108. 8.18.5 CSL Behring Recent Developments
  109. 8.19 Biotest
  110. 8.19.1 Biotest Company Information
  111. 8.19.2 Biotest Business Overview
  112. 8.19.3 Biotest Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Biotest Red Blood Cell Products Product Portfolio
  114. 8.19.5 Biotest Recent Developments
  115. 8.20 American Red Cross
  116. 8.20.1 American Red Cross Company Information
  117. 8.20.2 American Red Cross Business Overview
  118. 8.20.3 American Red Cross Red Blood Cell Products Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 American Red Cross Red Blood Cell Products Product Portfolio
  120. 8.20.5 American Red Cross Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Red Blood Cell Products Value Chain Analysis
  2. 9.1.1 Red Blood Cell Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Red Blood Cell Products Production Mode & Process
  6. 9.2 Red Blood Cell Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Red Blood Cell Products Distributors
  9. 9.2.3 Red Blood Cell Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst